Shih‐Te Tu

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed et al. · The Lancet · 2018 · 1.8K citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

Peter Rossing, Stefan D. Anker, Gerasimos Filippatos et al. · Diabetes Care · 2022 · 199 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study

Michael R. McClung, Michelle L. O’Donoghue, Socrates E. Papapoulos et al. · The Lancet Diabetes & Endocrinology · 2019 · 169 citations

Pharmacy, Pharmacotherapy, Bone Metabolism +10

The Influence of Type 2 Diabetes and Glucose-Lowering Therapies on Cancer Risk in the Taiwanese

Ming-Chia Hsieh, Tzu-Chi Lee, Shu-Min Cheng et al. · Experimental Diabetes Research · 2012 · 164 citations · Full text

Medicine, Endocrinology, Oncology +12

Case detection and diagnosis of primary aldosteronism – The consensus of Taiwan Society of Aldosteronism

Vin‐Cent Wu, Ya‐Hui Hu, Leay Kiaw Er et al. · Journal of the Formosan Medical Association · 2017 · 120 citations · Full text

Medicine, Endocrinology, Surgery +17